ACADIA Pharmaceuticals Inc.
USD25.20
-0.12 (-0.47%)
CEO
Catherine E. Owen Adams
IPO Date
2004-05-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$25.40
Prev. Close
$25.32
Day Low
$24.99
Day High
$25.40
52W Low
$19.69
52W High
$28.35
Market Cap
$4.32B
Volume
2.09M
| 13.4 |
| 31 Dec 2023 | FY | 93.7% | -8.4% | -14.2% | -8.2% | 0.13 | 2.42 | -83.7 |
| 31 Dec 2022 | FY | 98.0% | -41.8% | -53.9% | -36.7% | 0.15 | 4.04 | -11.9 |
| 31 Dec 2021 | FY | 96.0% | -34.7% | -31.0% | -24.0% | 0.12 | 6.43 | -22.3 |
| 31 Dec 2020 | FY | 95.3% | -63.7% | -44.9% | -36.0% | 0.08 | 6.77 | -29.9 |
| 31 Dec 2019 | FY | 94.2% | -69.4% | -33.7% | -30.0% | 0.01 | 10.16 | -26.8 |
| 31 Dec 2018 | FY | 91.8% | -109.6% | -51.2% | -45.4% | 0.00 | 8.83 | -8.3 |
| 31 Dec 2017 | FY | 89.5% | -231.7% | -86.3% | -75.3% | 0.00 | 7.62 | -12.8 |
| 31 Dec 2016 | FY | 74.6% | -1565.9% | -52.4% | -48.4% | 0.00 | 12.87 | -12.3 |
| 4.1 |
| 30 Sept 2025 | Q3 | 92.2% | 25.8% | 7.8% | 5.4% | 0.06 | 3.02 | 12.5 |
| 30 Jun 2025 | Q2 | 92.2% | 10.1% | 3.2% | 2.2% | 0.07 | 2.91 | 33.9 |
| 31 Mar 2025 | Q1 | 91.7% | 7.8% | 2.5% | 1.7% | 0.07 | 2.88 | 36.5 |
| 31 Dec 2024 | Q4 | 91.6% | 55.4% | 19.6% | 12.1% | 0.07 | 2.38 | 5.3 |
| 30 Sept 2024 | Q3 | 92.5% | 13.1% | 5.7% | 3.4% | 0.09 | 2.29 | 19.5 |
| 30 Jun 2024 | Q2 | 92.5% | 13.8% | 6.5% | 3.7% | 0.11 | 2.16 | 19.9 |
| 31 Mar 2024 | Q1 | 88.8% | 8.0% | 3.6% | 1.9% | 0.13 | 2.04 | 45.4 |
| 31 Dec 2023 | Q4 | 92.3% | 19.8% | 10.6% | 6.1% | 0.13 | 2.42 | 28.2 |